MicroPort NeuroScientific Corporation (HKG: 2172)
7.68
-0.23 (-2.91%)
Sep 9, 2024, 4:08 PM HKT
MicroPort NeuroScientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 774.66 | 665.62 | 547.35 | 382.8 | 221.92 | 183.72 |
Revenue Growth (YoY) | 20.94% | 21.61% | 42.99% | 72.49% | 20.79% | - |
Cost of Revenue | 200.48 | 153.83 | 154.35 | 84.45 | 57.14 | 37.27 |
Gross Profit | 574.17 | 511.79 | 393 | 298.35 | 164.78 | 146.45 |
Selling, General & Admin | 167.65 | 166.87 | 154.46 | 116.47 | 65.16 | 59.53 |
Research & Development | 128.95 | 165.13 | 123.27 | 94.13 | 53.04 | 38.17 |
Other Operating Expenses | -21.81 | -18.67 | -18 | -20.11 | -5.63 | -5.45 |
Operating Expenses | 274.79 | 313.34 | 259.72 | 190.5 | 112.57 | 92.24 |
Operating Income | 299.38 | 198.46 | 133.28 | 107.86 | 52.22 | 54.21 |
Interest Expense | -2.91 | -3.46 | -99.28 | -45.2 | -4.37 | -1.62 |
Interest & Investment Income | 15.94 | 16.57 | 9.97 | 3.96 | 0.14 | 0.05 |
Earnings From Equity Investments | -21.82 | -23.84 | -26.62 | -7.52 | - | - |
Currency Exchange Gain (Loss) | -0.64 | -0.64 | -0.54 | -0.16 | 0.38 | -0.14 |
Other Non Operating Income (Expenses) | -0.5 | -0.27 | -0.15 | -0.11 | -0.1 | -0.08 |
EBT Excluding Unusual Items | 289.46 | 186.82 | 16.67 | 58.83 | 48.27 | 52.43 |
Merger & Restructuring Charges | - | - | - | -0.98 | - | - |
Gain (Loss) on Sale of Investments | -24.63 | -24.63 | 1.7 | - | - | - |
Gain (Loss) on Sale of Assets | -0.13 | -0.13 | -0.03 | 0.39 | -0.07 | -0.02 |
Other Unusual Items | - | - | -22.66 | -26.34 | 3.2 | - |
Pretax Income | 264.69 | 162.05 | -4.33 | 31.9 | 51.4 | 52.41 |
Income Tax Expense | 48.03 | 27.47 | 20.35 | 7.73 | 6.11 | 5.44 |
Earnings From Continuing Operations | 216.67 | 134.58 | -24.68 | 24.17 | 45.29 | 46.98 |
Minority Interest in Earnings | 8.34 | 10.97 | 2.91 | - | - | - |
Net Income | 225.01 | 145.55 | -21.77 | 24.17 | 45.29 | 46.98 |
Net Income to Common | 225.01 | 145.55 | -21.77 | 24.17 | 45.29 | 46.98 |
Net Income Growth | 67.14% | - | - | -46.63% | -3.59% | - |
Shares Outstanding (Basic) | 582 | 583 | 518 | 495 | 456 | 421 |
Shares Outstanding (Diluted) | 582 | 583 | 518 | 495 | 456 | 421 |
Shares Change (YoY) | 0.65% | 12.58% | 4.46% | 8.76% | 8.20% | - |
EPS (Basic) | 0.39 | 0.25 | -0.04 | 0.05 | 0.10 | 0.11 |
EPS (Diluted) | 0.39 | 0.25 | -0.04 | 0.05 | 0.10 | 0.11 |
EPS Growth | 66.08% | - | - | -50.93% | -10.90% | - |
Free Cash Flow | - | 140.93 | 191.53 | 107.97 | 35.76 | 43.77 |
Free Cash Flow Per Share | - | 0.24 | 0.37 | 0.22 | 0.08 | 0.10 |
Dividend Per Share | 0.174 | 0.100 | - | - | - | - |
Gross Margin | 74.12% | 76.89% | 71.80% | 77.94% | 74.25% | 79.72% |
Operating Margin | 38.65% | 29.82% | 24.35% | 28.18% | 23.53% | 29.51% |
Profit Margin | 29.05% | 21.87% | -3.98% | 6.31% | 20.41% | 25.57% |
Free Cash Flow Margin | - | 21.17% | 34.99% | 28.21% | 16.11% | 23.82% |
EBITDA | 352.25 | 239.1 | 175.46 | 128.47 | 59.81 | 59.89 |
EBITDA Margin | 45.47% | 35.92% | 32.06% | 33.56% | 26.95% | 32.60% |
D&A For EBITDA | 52.87 | 40.64 | 42.18 | 20.61 | 7.59 | 5.67 |
EBIT | 299.38 | 198.46 | 133.28 | 107.86 | 52.22 | 54.21 |
EBIT Margin | 38.65% | 29.82% | 24.35% | 28.18% | 23.53% | 29.51% |
Effective Tax Rate | 18.14% | 16.95% | - | 24.24% | 11.89% | 10.37% |
Source: S&P Capital IQ. Standard template. Financial Sources.